WEGO Corporate and Strategy Overview
Revenue and profit breakdown
(by business segment)
Revenue breakdown
2022
Profit breakdown
2022
% of revenue
■Medical device
50.4%
■ Medical device
% of profit¹
41.5%
■ Orthopedic
Interventional
13.4%
■ Orthopedic
18.4%
12.7%
■Interventional
4.7%
Pharma packaging
15.5%
Pharma packaging
28.6%
Blood management
8.0%
Blood management
6.8%
Revenue by business segment
(RMBmm)
Profit by business segment
(RMBmm)
2022
20213
2022
20213
Medical device product
6,859
6,464
Medical device product
1,298
927
Orthopedic products
1,830
2,127
Orthopedic products
576
762
Interventional products
1,726
1,544
Interventional products
147
151
Pharma packaging products
2,105
2,040
Pharma packaging products
896
855
Blood management
1,098
977
Blood management
211
170
Total
13,619
13,152
Total
3,1942
2,9402
WEGO威高
Note: 1 The calculation of profit breakdown does not include other segment profits of RMB64.02mm; 2 The total includes other segment profits of RMB64.02mm (2022)
and RMB74.58mm (2021), which are not listed separately; 3 Not including the impact of accounting restatement of business under the same control in 2021.
The above figures are only for the purpose of reflecting the trend at the operational level of the Company. The specific figures are subject to performance reports.
18View entire presentation